Eli Lilly Abandons Weight Loss Pill Trials!
This episode of On The Pen: The Weekly Dose Podcast breaks down four major stories in obesity medicine: the FDA’s approval of Teva’s so-called “generic” Saxenda at a sky-high price, Wegovy’s accelerated approval in MASH, Novo Nordisk’s headline-grabbing but shaky 57% cardiovascular benefit claim, and Eli Lilly’s decision to scrap its oral GLP-1 naperiglipron. We cut through the spin to ask what these developments really mean for patients fighting for access and better treatment options.
Visit All Our Links
https://linktr.ee/manonthemounjaro
GLP-1 Heart Study
https://onthepen.substack.com/p/new-study-glp-1-drugs-protect-the
As seen on YouTube.
Related in [Weight loss]:
- Q & A With Dr. Dixit For 7th Weight Loss Challenge
- Jump Start Weight Loss Over 50 | Do This Today
- Easy And Healthy Smoothie For Detox And Weight Loss #healthy #smoothie #mom #recipe #healthydrink
- 10 Min Yoga For Weight Loss | Beginner-Intermediate Flow With Sheena, Short Yoga Class At Home
- ☑️ ওজন কমানোর সঠিক পথ । নিজের ওজন নিজেই কমান । Weight Loss Diet। Dr. Aloke Debnath ।
Other posts:
- 3 Exercises To Get Rid Of Man Boobs FAST In 30 Days!
- Uninterrupted Twilight Zone Radio Dramas | 7 Hours | Full Episodes Compilation
- The Mandalorian | Official Trailer | Disney+ | Streaming Nov. 12
- The Return Of Screweyes Trailer
- The Struggles Of Bodybuilding (My Big Decision)
